'Reversing' the symptoms of asthma

University of New South Wales researchers have developed a compound that has had a surprise result: being effective in the prevention of asthma.

The compound was originally developed to treat leukaemia.

The research, led by the University of Newcastle, has been published in Nature Medicine. It centres on the role played by two proteins in the lungs in causing asthma attacks.

When they come into contact with the and , the two main asthma triggers, they work together to produce a series of events that cause an attack.

The research shows that the UNSW-developed compound is able to activate a protein that is suppressed during asthma. This could mean that in the future doctors would be able to treat the cause of asthma, not just the symptoms.

"Asthma is one of the major diseases of the developed world. It's very rare to find a compound that can reverse the symptoms of asthma," says Dr Anthony Don, who started working on the compound in the treatment of acute .

"The important thing with this compound is that it's not just alleviating the symptoms, it's hitting at an underlying disease mechanism," says Dr Don, a team leader at UNSW's Lowy Cancer Research Centre.

Associate Professor Jonathan Morris from the School of Chemistry synthesized the compound.

The development is also significant because are currently treated similiarly regardless of whether they are caused by viruses or allergens, but virus-induced effects are much less responsive to current therapies.

The compound could also be used in the treatment of other inflammatory diseases.

add to favorites email to friend print save as pdf

Related Stories

Bacteria to blame in asthma attacks in children

Oct 07, 2010

Doctors have long known that viral infections can bring about asthma attacks and the shortness of breath, coughing, and wheezing associated with them. But while viral infections cannot be treated, scientists at the Danish ...

Study reveals new link to asthma

Aug 23, 2012

(Medical Xpress)—Researchers at King's have established a significant link between asthma and an immune response called 'Th17', previously only attributed to inflammatory conditions such as multiple sclerosis.

Recommended for you

A better biomonitor for children with asthma

Dec 10, 2014

For the firefighters and rescue workers conducting the rescue and cleanup operations at Ground Zero from September 2001 to May 2002, exposure to hazardous airborne particles led to a disturbing "WTC cough"—obstructed ...

New insight into risk of Ankylosing Spondylitis

Dec 09, 2014

Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis.

Novel approach to treating asthma: Neutralize the trigger

Dec 03, 2014

Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists ...

Inflammatory discovery sheds new light on skin disease

Dec 02, 2014

Inflammatory skin diseases such as psoriasis may result from abnormal activation of cell death pathways previously believed to suppress inflammation, a surprise finding that could help to develop new ways ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

dirk_bruere
not rated yet Jan 22, 2013
So what's the compound?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.